Jiangsu Hengrui Medicine Co Ltd Strategic Asset Allocation Index
Jiangsu Hengrui Medicine Co Ltd strategic asset allocation index. Jiangsu Hengrui Medicine Co Ltd (600276) has a Strategic Asset Allocation Index of 17.0% as of June 2023. Strategic assets (PP&E of CN¥6.69 Billion plus long-term investments of CN¥-) total CN¥6.69 Billion, measured against net assets of CN¥39.44 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Jiangsu Hengrui Medicine Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Jiangsu Hengrui Medicine Co Ltd (2000–2021)
Strategic asset allocation index of Jiangsu Hengrui Medicine Co Ltd from 2000 to 2021. This chart shows how Jiangsu Hengrui Medicine Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 17.0%, representing strategic assets of CN¥6.69 Billion against net assets of CN¥39.44 Billion CNY.
Jiangsu Hengrui Medicine Co Ltd Strategic Asset Allocation Index by Year (2000–2021)
Jiangsu Hengrui Medicine Co Ltd strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Hengrui Medicine Co Ltd from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Jiangsu Hengrui Medicine Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 17.6% | CN¥6.28 Billion | CN¥6.28 Billion | CN¥- | CN¥35.57 Billion | ▲ +2.7 pp |
| 2020 | 14.9% | CN¥4.59 Billion | CN¥4.59 Billion | CN¥- | CN¥30.79 Billion | ▼ -3.9 pp |
| 2019 | 18.7% | CN¥4.67 Billion | CN¥4.07 Billion | CN¥599.43 Million | CN¥24.94 Billion | ▼ -0.7 pp |
| 2018 | 19.4% | CN¥3.84 Billion | CN¥3.69 Billion | CN¥155.65 Million | CN¥19.80 Billion | ▼ -0.6 pp |
| 2017 | 20.0% | CN¥3.20 Billion | CN¥3.08 Billion | CN¥117.53 Million | CN¥15.94 Billion | ▲ +0.2 pp |
| 2016 | 19.8% | CN¥2.55 Billion | CN¥2.47 Billion | CN¥81.04 Million | CN¥12.87 Billion | ▲ +2.0 pp |
| 2015 | 17.9% | CN¥1.85 Billion | CN¥1.77 Billion | CN¥78.93 Million | CN¥10.36 Billion | ▼ -1.7 pp |
| 2014 | 19.6% | CN¥1.62 Billion | CN¥1.62 Billion | CN¥- | CN¥8.29 Billion | ▼ -6.9 pp |
| 2013 | 26.5% | CN¥1.77 Billion | CN¥1.77 Billion | CN¥- | CN¥6.66 Billion | ▲ +2.0 pp |
| 2012 | 24.6% | CN¥1.34 Billion | CN¥1.34 Billion | CN¥- | CN¥5.44 Billion | ▲ +0.9 pp |
| 2011 | 23.7% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥4.38 Billion | ▲ +0.3 pp |
| 2010 | 23.4% | CN¥813.15 Million | CN¥813.15 Million | CN¥- | CN¥3.47 Billion | ▲ +0.5 pp |
| 2009 | 22.9% | CN¥609.25 Million | CN¥609.25 Million | CN¥- | CN¥2.67 Billion | ▼ -4.0 pp |
| 2008 | 26.9% | CN¥543.97 Million | CN¥543.97 Million | CN¥- | CN¥2.02 Billion | ▼ -3.8 pp |
| 2007 | 30.7% | CN¥501.25 Million | CN¥501.25 Million | CN¥- | CN¥1.63 Billion | ▼ -9.8 pp |
| 2006 | 40.5% | CN¥508.53 Million | CN¥508.53 Million | CN¥- | CN¥1.26 Billion | ▼ -2.9 pp |
| 2005 | 43.3% | CN¥479.99 Million | CN¥479.99 Million | CN¥- | CN¥1.11 Billion | ▼ -5.9 pp |
| 2004 | 49.2% | CN¥491.12 Million | CN¥491.12 Million | CN¥- | CN¥998.05 Million | ▼ -27.4 pp |
| 2003 | 76.6% | CN¥692.36 Million | CN¥692.36 Million | CN¥- | CN¥903.35 Million | ▲ +8.9 pp |
| 2002 | 67.8% | CN¥548.79 Million | CN¥548.79 Million | CN¥- | CN¥809.97 Million | ▲ +12.3 pp |
| 2001 | 55.5% | CN¥420.49 Million | CN¥420.49 Million | CN¥- | CN¥757.99 Million | ▲ +26.5 pp |
| 2000 | 29.0% | CN¥195.17 Million | CN¥195.17 Million | CN¥- | CN¥672.57 Million | — |